SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-059923
Filing Date
2009-03-20
Accepted
2009-03-20 17:13:43
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1361657
2 PROCESS DEVELOPMENT AGREEMENT dex10103.htm EX-10.103 127091
3 AMENDMENT TO AMENDED AND RESTATED 2001 INCENTIVE PLAN OF THE COMPANY dex10104.htm EX-10.104 7188
4 TERMINATION LETTER AGREEMENT dex10105.htm EX-10.105 5690
5 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2265
6 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9442
7 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9222
8 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3251
9 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3273
10 GRAPHIC g26957ex10_105pg001.jpg GRAPHIC 10798
  Complete submission text file 0001193125-09-059923.txt   1545680
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31361 | Film No.: 09697011
SIC: 2834 Pharmaceutical Preparations